Related references
Note: Only part of the references are listed.Role of advanced glycation end products and insulin resistance in diabetic nephropathy
Kirti Parwani et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2023)
Daidzein suppresses TGF-β1-induced cardiac fibroblast activation via the TGF-β1/SMAD2/3 signaling pathway
Jiangcheng Shu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Antimicrobial Alkaloids from Marine-Derived Fungi as Drug Leads versus COVID-19 Infection: A Computational Approach to Explore their Anti-COVID-19 Activity and ADMET Properties
Sherouk Hussein Sweilam et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2022)
3-Arylcoumarin inhibits vascular calcification by inhibiting the generation of AGEs and anti-oxidative stress
YuFei Li et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy
Hong Zhou et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Daidzein mitigates myocardial injury in streptozotocin-induced diabetes in rats
Ankit P. Laddha et al.
LIFE SCIENCES (2021)
CD-1db/dbmice: A novel type 2 diabetic mouse model with progressive kidney fibrosis
Yuiko Mizunuma et al.
JOURNAL OF DIABETES INVESTIGATION (2020)
ADMET modeling approaches in drug discovery
Leonardo L. G. Ferreira et al.
DRUG DISCOVERY TODAY (2019)
Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents
Yuheng Hu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetes patients with diabetic nephropathy
Miho Shimizu et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors
Kamal M. El-Gamal et al.
JOURNAL OF MOLECULAR STRUCTURE (2018)
Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy
Giacomo Garibotto et al.
JOURNAL OF NEPHROLOGY (2017)
Evaluation the cytotoxic effect of cytotoxin-producing Klebsiella oxytoca isolates on the HEp-2 cell line by MTT assay
Mohammad Mehdi Soltan-Dallal et al.
MICROBIAL PATHOGENESIS (2017)
Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects
Yunjeong Kim et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
Hillel Sternlicht et al.
BLOOD PURIFICATION (2016)
Silent diabetic nephropathy
Samar M. Said et al.
KIDNEY INTERNATIONAL (2016)
Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms
Luigi Gnudi et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Phenological and geographical influence in the concentration of selected bioactive 4-phenylcoumarins and chlorogenic acid in Hintonia latiflora leaves
S. Cristians et al.
JOURNAL OF ETHNOPHARMACOLOGY (2014)
Hypertension in Diabetic Nephropathy: Epidemiology, Mechanisms, and Management
Peter N. Van Buren et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2011)
Genetic associations in diabetic nephropathy: a meta-analysis
A. L. Mooyaart et al.
DIABETOLOGIA (2011)
Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats
Atul Arya et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
Shinji Kume et al.
PPAR RESEARCH (2008)
Acute toxicity and mutagenic activity of Mexican plants used in traditional medicine
Myrna Deciga-Campos et al.
JOURNAL OF ETHNOPHARMACOLOGY (2007)
Diabetic nephropathy: Recent insights into the pathophysiology and the progression of diabetic nephropathy
ML Gross et al.
KIDNEY INTERNATIONAL (2005)
Genetic aspects of diabetic nephropathy
TH Lindner et al.
KIDNEY INTERNATIONAL (2003)
Share Paper
